Zhejiang Langhua Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SPIRONOLACTONE, with a corresponding US DMF Number 26881.
Remarkably, this DMF maintains an Active status since its submission on February 04, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 27, 2016, and payment made on August 12, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II